<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39419666</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-3096</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>16</Day></PubDate></JournalIssue><Title>Trends in biotechnology</Title><ISOAbbreviation>Trends Biotechnol</ISOAbbreviation></Journal><ArticleTitle>Molecular farming for the food sector.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0167-7799(24)00276-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tibtech.2024.09.015</ELocationID><Abstract><AbstractText>Molecular farming, initially developed to produce therapeutic proteins using genetically modified plants, gained renewed interest during the Ebola and COVID-19 outbreaks and has expanded into functional food ingredients. This article evaluates molecular farming technologies, market potential, and startups, and identifies opportunities in dairy proteins, food enzymes, collagen, and cellular agriculture.</AbstractText><CopyrightInformation>Copyright Â© 2024 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Turetta</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cereal Docks S.p.A., Via dell'Innovazione, 1, - 36043 Camisano Vicentino, VI, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leonardi</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Grey Silo Ventures S.r.l., Via dell'Innovazione, 1, - 36043 Camisano Vicentino, VI, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reniero</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Grey Silo Ventures S.r.l., Via dell'Innovazione, 1, - 36043 Camisano Vicentino, VI, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alpi</LastName><ForeName>Amedeo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Accademia dei Georgofili, Logge Uffizi Corti, 50122 Firenze, FI, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costanzo</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cereal Docks S.p.A., Via dell'Innovazione, 1, - 36043 Camisano Vicentino, VI, Italy; Grey Silo Ventures S.r.l., Via dell'Innovazione, 1, - 36043 Camisano Vicentino, VI, Italy. Electronic address: enricocostanzo@cerealdocks.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trends Biotechnol</MedlineTA><NlmUniqueID>8310903</NlmUniqueID><ISSNLinking>0167-7799</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">food tech</Keyword><Keyword MajorTopicYN="N">genetic transformation</Keyword><Keyword MajorTopicYN="N">gmo</Keyword><Keyword MajorTopicYN="N">molecular farming</Keyword><Keyword MajorTopicYN="N">startup</Keyword><Keyword MajorTopicYN="N">venture capital</Keyword></KeywordList><CoiStatement>Declaration of interests The authors have no competing interests to declare. There were no investments made by Grey Silo Ventures in any of the startups mentioned in the article. The authors are not on the Board or Advisory Board of any of the companies listed in the article. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>7</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>7</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>21</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39419666</ArticleId><ArticleId IdType="doi">10.1016/j.tibtech.2024.09.015</ArticleId><ArticleId IdType="pii">S0167-7799(24)00276-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle>